Investing.com - Corbus Pharmaceuticals Holding reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Corbus Pharmaceuticals Holding announced earnings per share of $-0.0700 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.0600 on revenue of $220K.
Corbus Pharmaceuticals Holding shares are down 41.36% from the beginning of the year and are trading at $0.1275 , down-from-52-week-high.
Corbus Pharmaceuticals Holding shares lost 1.92% in intra-day trade after the report.
Corbus Pharmaceuticals Holding follows other major Healthcare sector earnings this month
Corbus Pharmaceuticals Holding's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar